Thursday, May 05, 2011 7:51:01 PM
BELGRADE, Mont., May 4, 2011 -- /PRNewswire/ -- Bacterin International Holdings, Inc. ("Bacterin") (NYSE Amex: BONE), a developer of revolutionary bone graft material, today announced that its chairman and CEO, Guy Cook, will present at SEVEN; Noble Financial Capital Markets' Seventh Annual Equity Conference at the Hard Rock Hotel in Hollywood, Florida, on Monday, May 16, 2011 at 4:00p.m. Eastern Time.
At the time of the presentation, a live audio and high-definition video webcast of Bacterin's presentation and a copy of the presentation materials will be available on the Company's website www.bacterin.com, or through the Noble Financial websites: www.noblefcm.com, or www.noble7.com. Bacterin recommends registering at least 10 minutes prior to the start of the presentation to ensure timely access. You will require a Microsoft SilverLight viewer (a free download from the presentation link) to participate. The webcast and presentation will also archived on the Bacterin website for 90 days following the event.
About Bacterin International Holdings, Inc.
BACTERIN INTERNATIONAL HOLDINGS, INC. ("the "Company" or "Bacterin") develops, manufactures and markets biologics products to domestic and international markets. Bacterin's proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold and promote bone and other tissue growth. These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain with a facet joint stabilization, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries.
Bacterin's Medical Device division develops anti-microbial coatings based upon proprietary coating technologies. Bacterin develops, employs, and licenses bioactive coatings for various medical device applications. Bacterin's strategic coating initiatives include antimicrobial coatings designed to inhibit biofilm formation and microbial contamination. Headquartered in Belgrade, Montana, Bacterin operates a 32,000 square foot, state-of-the-art, fully compliant and FDA registered facility, equipped with five "Class 100" clean rooms. For further information please visit www.bacterin.com.
About Noble Financial
Noble Financial Capital Markets was established in 1984 and is an equity research driven, full-service, investment banking boutique focused on small-cap, emerging growth companies. The company has offices in New York, Boston, New Jersey, St Louis, and Boca Raton. In addition to non-deal road shows and sector-specific conferences throughout the year, Noble Financial hosts its large format annual equity conference in late spring featuring 120 – 150 presenting companies from across North America and total attendance of close to 600. For more information: www.noblefcm.com
Recent XTNT News
- Xtant Medical Announces Launch of SimpliGraft™ and SimpliMax™ for Chronic and Acute Wounds • GlobeNewswire Inc. • 04/30/2024 09:00:00 AM
- Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million • GlobeNewswire Inc. • 04/01/2024 11:00:00 AM
- Xtant Medical to Issue Fourth Quarter and Full Year 2023 Financial Results on April 1, 2024 • GlobeNewswire Inc. • 03/21/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 10:13:22 PM
- Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial • GlobeNewswire Inc. • 03/07/2024 09:05:00 PM
- Xtant Medical to Present at the TD Cowen 44th Annual Healthcare Conference • GlobeNewswire Inc. • 02/26/2024 09:05:00 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 02/16/2024 09:05:39 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 10:10:19 PM
- Xtant Medical to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/05/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 09:11:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 09:42:41 PM
- Xtant Medical to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 11/09/2023 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 12:15:30 PM
- Xtant Medical Announces Record Third Quarter Revenue of $25 Million • GlobeNewswire Inc. • 11/09/2023 12:00:00 PM
- Xtant Medical to Issue Third Quarter 2023 Financial Results on November 9, 2023 • GlobeNewswire Inc. • 11/02/2023 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2023 09:00:32 PM
- Xtant Medical Announces Acquisition of nanOss Production Operations from RTI Surgical • GlobeNewswire Inc. • 10/23/2023 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/17/2023 08:43:14 PM
- Xtant Medical Highlights Growing Product Portfolio at NASS 2023 • GlobeNewswire Inc. • 10/12/2023 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/18/2023 08:15:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/17/2023 09:20:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/17/2023 09:11:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/17/2023 09:01:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/17/2023 08:46:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/17/2023 08:38:39 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM